M C Rousselet — Page 4

PubMed1985

[Prostatic carcinoma: histoprognosis, prognostic value of Gleason's index].

This paper recalls the definition of the Gleason index and describes the five architectural types that enable a calculation of the index. The conditions of the practical application of the index are defined, with a discussion of reproducibility of results based on current literature and the author's experience. The index allows appreciation of the developmental potential of prostatic cancer and distinguishes between patients with a high risk of metastases and death from the cancer and those with low potential development. While the Gleason index cannot predict the course of the tumour in any given patient, it can be considered a useful element among the clinical and biological factors assessed in the prognosis of prostatic carcinoma.

Adenocarcinoma↗

PubMedDate not supplied

Investigation of bound water in frozen precancerous rat liver tissue by proton NMR.

The proton NMR spin lattice relaxation times of bound water (T1b) were studied on frozen rat liver samples during the precancerous step of cancer induction by diethylnitrosamine. Two components of the T1b were found, which show a different temperature dependence of their relative magnetization. Four different steps were identified during the experimental cancer induction according to 1H NMR findings, while only three were distinguished after histological examination. The results point to the influence of cross-relaxation and corroborate previous reports on differences observed between the heat capacity of normal and tumorous tissues.

Animals↗

PubMedDate not supplied

[Neurosarcoma of the Treitz fossa. Apropos of a case].

A unique neurosarcoma was observed located in the Treitz' fossa. Such tumours are usually occur in Rechlinghausent's disease and are exception in isolated situations. Diagnosis is difficult and requires a small bowel study. Surgical exeresis is the only treatment.

Aged↗

PubMedDate not supplied

Measurement of collateral circulation blood flow in anesthetized portal hypertensive rats.

AIMS: The aim of this study was to develop a technique to measure collateral blood flow in portal hypertensive rats. METHODS: Morphological techniques included inspection, casts and angiographies of portosystemic shunts. The main hemodynamic measurements were splenorenal shunt blood flow (transit time ultrasound method), percentage of portosystemic shunts and regional blood flows (microsphere method). In study 1, a model of esophageal varices was developed by ligating the splenorenal shunt. In study 2, morphological studies of the splenorenal shunt were performed in rats with portal vein ligation. In study 3, the relationship between splenorenal shunt blood flow with percentage of portosystemic shunts was evaluated in dimethylnitrosamine cirrhosis. In study 4, secondary biliary, CCl4 and dimethylnitrosamine cirrhosis were compared. In study 5, rats with portal vein ligation received acute administration of octreotide. In study 6, rats with dimethylnitrosamine cirrhosis received acute administration of vapreotide. RESULTS: Blood flow of para-esophageal varices could not be measured. SRS blood flow was correlated with the mesenteric percentage of portosystemic shunts (r = 0.74, P < 0.05), splenic percentage of portosystemic shunts (r = 0.54, P < 0.05) and estimated portosystemic blood flow (r = 0.91, P < 0.01). Splenorenal shunt blood flow was 6 to 12 times higher in portal hypertensive rats, e.g., in portal vein ligated rats: 2.8 +/- 2.7 vs 0.3 +/- 0.1 mL.min-1 in sham rats (P < 0.01), and was similar in the different cirrhosis models but was higher in portal vein ligated rats than in cirrhotic rats (1.2 +/- 0.7 vs 0.6 +/- 0.6 mL.min-1.100 g-1, P = 0.05). Octreotide significantly decreased splenorenal shunt blood flow: -23 +/- 20% (P < 0.01) vs -6 +/- 8% (not significant) in placebo rats. The variation of splenorenal shunt blood flow after vapreotide was significant but not that of the splenic percentage of portosystemic shunts compared to placebo. CONCLUSIONS: The splenorenal shunt is the main portosystemic shunt in rats. The measurement of splenorenal shunt blood flow is easy, accurate and reproducible and should replace the traditional measurement of the percentage of portosystemic shunts in pharmacological studies.

Animals↗